Public tenders for chemical in Ottawa-on Canada

Find all Chemical tenders in the world.
Finding business opportunities has never been easier.

Results for chemical. Make a new search!

EQUINE DRUG TESTING SERVICES

Public Works & Government Services Canada | Published October 3, 2014
cpvs

DESCRIPTION : The Canadian Pari-Mutuel Agency (CPMA) of Agriculture and Agri-Food Canada (AAFC) is a federal regulatory agency with a mandate to regulate and supervise pari-mutuel betting in Canada on horse racing, with the objective of ensuring that pari-mutuel betting is conducted in a way that is fair to the betting public. One of the key activities undertaken by the CPMA in advancing this mandate is the operation of a national drug control program in accordance with the Pari-Mutuel Betting Supervision Regulations (the Regulations) (http://laws.justice.gc.ca/en/showtdm/cr/SOR-91-365) enacted under the Criminal Code aimed at preventing and detecting the use of prohibited drugs and medication in race horses. In this regard the CPMA requires the services of a laboratory that will become an “Official Laboratory” as defined under Section 2 of the Regulations. This designated Official Laboratory will provide services to prevent and detect the uncontrolled use of drugs and medications in racing horses, through: (1) analytical services in respect of official samples of equine body fluids and other materials obtained from horses racing in pari-mutuel races at Canadian racetracks; and, (2) research services on an “as and when requested” basis, with respect to the detection and identification of drugs and metabolites in horses through the analysis of urine and blood obtained from horses which have been administered drugs under controlled conditions. Services will be required for a period commencing from date of contract award (estimated to be from April 1, 2015) up to and including March 31, 2018, with an irrevocable option on the part of Canada to extend the contract period of any resultant contract by up to two (2) additional one (1) year periods. OFFICIAL LABORATORY : The successful Bidder’s laboratory will be designated by the Executive Director of the CPMA as an Official Laboratory under the Pari-Mutuel Betting Supervision Regulations (the Regulations). In order to be designated as the CPMA’s “Official Laboratory”, the Contractor must be accredited by the Standards Council of Canada (SCC) as described in Appendix 2 of Annex A of this RFP. In the case that the successful Bidder’s laboratory is accredited under ISO/IEC 17025 in the Forensic Testing Program specialty area as a Drug Chemistry or Toxicology laboratory (CAN-P-1578, Appendices 1 & 6) but not as an Equine Drug Testing laboratory, the Bidder must successfully complete a scope expansion to cover Equine Drug Testing (CAN-P-1578 Appendix 4) prior to Contract Award. At Bid closing, the Bidder must demonstrate that the laboratory proposed to carry out the Work has submitted a request for scope expansion to cover Equine Drug Testing (CAN-P-1578) to the Standards Council of Canada and must provide a copy of the Standards Council of Canada’s acknowledgement to the request. TRADE AGREEMENTS : The requirement is subject to the provisions of the Agreement on Internal Trade (AIT). The requirement is for Commercial Testing Laboratory Services (GSIN: H300C) which are excluded from the application of the North American Free Trade Agreement (NAFTA) as per Annex 1001.1b-2, Class H3, Inspection Services (incl. Commercial Testing Laboratory Services except Medical/Dental). The requirement is excepted from the application of World Trade Organization - Agreement on Government Procurement (WTO-AGP) under Article XXIII, Exceptions to the Agreement, as follows; “subject to the requirement that such measures are not applied in a manner which would constitute a means of arbitrary or unjustifiable discrimination between countries where the same conditions prevail or a disguised restriction on international trade, nothing in this Agreement must be construed to prevent any Party from imposing or enforcing measures: necessary to protect public morals, order or safety...” The Comprehensive Land Claims Agreements (CLCAs) are not applicable to this procurement, as the Work will not be delivered to, nor conducted within CLCA areas. INTELLECTUAL PROPERTY : Canada will own the Intellectual Property Rights in Foreground Information as per 6.4.1 'the main purpose of the Contract and deliverables contract is to generate knowledge and information for public dissemination'. MANDATORY TECHNICAL EVALUATION CRITERIA : Any Bid that fails to meet the Mandatory Requirements stipulated below will be deemed non-responsive and will be given no further consideration. At Bid closing time, the Bidder must comply with the Mandatory Requirements. The Bidder is required to provide the necessary documentary evidence to support compliance. The Contracting Authority may request any supporting documentation from the Bidder to validate, demonstrate or support the Bidder’s compliance with any of the criteria listed below prior to Contract Award. Failure to comply with the request of the Contracting Authority will render the bid non-responsive. A resource may only be proposed for a single Category of work. A resource can be proposed as either a technical support personnel or a research technician but not both. Listing experience without providing any supporting data to describe where, when and how such experience was obtained may result in the experience not being included for evaluation purposes. MR-1. At Bid Closing, the Bidder’s laboratory proposed to perform the work must be accredited by the Standards Council of Canada (SCC) under ISO/IEC 17025 in the Forensic Testing Program specialty area as a Forensic Equine Drug Testing laboratory (CAN-P-1578, Appendix 4); OR, At Bid Closing, the Bidder’s laboratory proposed to perform the work must be accredited under ISO/IEC 17025 in the Forensic Testing Program specialty area as a Drug Chemistry or Toxicology laboratory (CAN-P-1578, Appendices 1 & 6) with a scope that includes analytical instrumentation and methodology for the analysis of drugs included in (but not limited to) the Schedule to the Pari-Mutuel Betting Supervision Regulations, according to Part V of the Regulations (http://laws.justice.gc.ca/eng/regulations/sor-91-365/index.html). In the case that the successful Bidder’s laboratory is accredited under ISO/IEC 17025 in the Forensic Testing Program specialty area as a Drug Chemistry or Toxicology laboratory (CAN-P-1578, Appendices 1 & 6) but not as an Equine Drug Testing laboratory, the Bidder must successfully complete a scope expansion to cover Equine Drug Testing (CAN-P-1578 Appendix 4) prior to Contract Award. The Bidder must provide a copy of the Bidder’s accredited scope and accreditation certificate for Forensic Equine Drug Testing (CAN-P-1578, Appendix 4), Drug Chemistry (CAN-P-1578, Appendix 1) or Toxicology (CAN-P-1578, Appendix 6). In the case that the Bidder’s laboratory proposed to perform is accredited under ISO/IEC 17025 in the Forensic Testing Program specialty area as a Drug Chemistry or Toxicology laboratory (CAN-P-1578, Appendices 1 & 6), the Bidder must demonstrate and provide evidence that, no later than the date of Bid Closing, the laboratory proposed to carry out the Work has submitted a request for scope expansion to cover Equine Drug Testing (CAN-P-1578) to the Standards Council of Canada and must also provide a copy of the Standards Council of Canada’s acknowledgement to the request. MR-2. The Bidder must provide a current curriculum vitae (CV) for the individuals proposed and a reference contact to validate the information in the CV for each resource described below: • a minimum of three Analytical Chemists; • a minimum of three Technical Support Personnel for the analysis of official samples on a daily basis; • two Research Scientists; • two Research Technicians; and, • one Quality Manager. Reference checks may be conducted to validate information provided in the curriculum vitae only. MR-3. The Bidder must provide Standard Operating Procedures (SOPs) from the laboratory proposed to perform the Work for the operation of the following analytical instruments to use for detection and confirmation of scheduled drugs: • High performance liquid chromatography - mass spectrometry (HPLC/MS/MS) • Enzyme-linked immunosorbent assay (ELISA (automated plate reader)) • High performance liquid chromatography - fluorescence detection (HPLC/FL) MR-4. Analytical Chemists (3) The Bidder’s laboratory proposed to perform the Work must provide the services of a minimum of three (3) analytical chemists who are each eligible to be designated by the Executive Director of the CPMA as an Official Chemist as per the Regulations. Prerequisites to be eligible for designation as an Official Chemist are included below. For each proposed Analytical Chemist the Bidder must provide evidence of (the Bidder is requested to use the Experience Description Form 1.1, “MR-4 : Analytical Chemist” provided in Attachment 1 to Part 4): a) at a minimum, a Bachelor’s degree in a chemical science from a recognized Canadian university, or the equivalent as established by a recognized Canadian academic credentials assessment service*, if obtained outside Canada. The Bidder must submit a copy of the degree; and, *The list of recognized assessment organizations can be found under the Canadian Information Centre for International Credentials website, at the following internet link: http://www.cicic.ca/indexe.stm. b) a minimum of three (3) years of practical experience within the last five (5) years measured back from the date of Bid Closing in analytical procedures using HPLC-MS-MS, with experience in any combination of pharmacology, pharmaceutical chemistry, analytical or forensic toxicology, biopharmaceutics or medicinal chemistry; and, c) a minimum of one (1) year continuous employment within the last two (2) years measured back from the date of Bid Closing in a capacity directly involved on a day-to-day basis with the analysis of samples in a laboratory that has been accredited by the Standards Council of Canada under ISO/IEC 17025 in the Forensic Testing Program specialty area as a Forensic Equine Drug Testing laboratory (CAN-P-1578 Appendix 4); or, a Laboratory that has been accredited under ISO/IEC 17025 in the Forensic Testing Program specialty area as a Drug Chemistry or Toxicology laboratory (CAN-P-1578, Appendices 1 and 6). The first three resources proposed listed sequentially will be evaluated. Additional resources proposed will not be evaluated for the purposes of the Technical Evaluation, however, all resources will be required to meet the minimum qualifications detailed under the Statement of Work. MR-5. Technical Support Personnel (3) The Bidder’s laboratory performing the Work must provide the services of a minimum of three technical support personnel for the analysis of official samples on a daily basis. For each proposed Technical Support Personnel the Bidder must provide evidence of (the Bidder is requested to use the Experience Description Form 1.2, “MR-5: Technical Support Personnel” provided in Attachment 1 to Part 4): a) at a minimum, a college diploma in a chemistry-related field from a recognized academic institution. The Bidder must submit a copy of the diploma; and, b) a minimum of two (2) years experience within the last five (5) years measured back from the date of bid closing in a chemistry-related field. The first three resources proposed listed sequentially will be evaluated. Additional resources proposed will not be evaluated for the purposes of the Technical Evaluation, however, all resources will be required to meet the minimum qualifications detailed under the Statement of Work. MR-6. Research Scientist (2) The Bidder must provide the services of two Research Scientists to perform research and method development according to specifications and project requirements of the CPMA described in the Statement of Work at Annex A. For each proposed Research Scientist the Bidder must provide evidence of (the Bidder is requested to use the Experience Description Form 1.3, “MR-6 : Research Scientist” provided in Attachment 1 to Part 4): a) at a minimum, a doctoral degree (PhD) in a chemical science related field from a recognized Canadian University, or the equivalent as established by a recognized Canadian academic credential assessment service*, if obtained outside Canada. The Bidder must submit a copy of the degree; and, *The list of recognized assessment organizations can be found under the Canadian Information Centre for International Credentials website, at the following internet link: http://www.cicic.ca/indexe.stm b) a minimum of three (3) years experience within the last five (5) years measured back from the date of bid closing in development of analytical methods involving HPLC-MS-MS for pharmaceutical substances in body fluids; and, c) a minimum of three (3) scientific publications authored by the proposed Research Scientist demonstrating evidence of experience in chemical science research within the last five (5) years measured back from the date of bid closing. A list of Publication references or a copy of the Publications must be submitted. The first two resources proposed listed sequentially will be evaluated. Additional resources proposed will not be evaluated for the purposes of the Technical Evaluation, however, all resources will be required to meet the minimum qualifications detailed under the Statement of Work. MR-7. Research Technician (2) The Bidder must provide the services of two Research Technicians to provide support in the research and method development activities according to specifications and project requirements of the CPMA described in the Statement of Work at Annex A. For each proposed Research Technician the Bidder must provide evidence of (the Bidder is requested to use the Experience Description Form 1.4, “MR-7: Research Technician” provided in Attachment 1 to Part): a) at a minimum, a college diploma in a chemistry-related field from a recognized Canadian academic institution, or the equivalent as established by a recognized Canadian academic credential assessment service*, if obtained outside Canada. The Bidder must submit a copy of the diploma; and *The list of recognized assessment organizations can be found under the Canadian Information Centre for International Credentials website, at the following internet link: http://www.cicic.ca/indexe.stm b) a minimum of two (2) consecutive years experience within the last five (5) years measured back from the date of bid closing in a chemical-related field. The first two resources proposed listed sequentially will be evaluated. Additional resources proposed will not be evaluated for the purposes of the Technical Evaluation, however, all resources will be required to meet the minimum qualifications detailed under the Statement of Work. MR-8. Quality Manager (1) The Bidder’s laboratory performing the Work must provide the services of one Quality Manager. For the proposed Quality Manager the Bidder must provide evidence of (the Bidder is requested to use the Experience Description Form 1.5, “MR-8 : Quality Manager” provided in Attachment 1 to Part 4): a) training in ISO/IEC 17025 and internal auditing*; and, b) a minimum of one (1) year of current and consecutive experience measured back from the date of bid closing as a Quality Manager. *Acceptable evidence is a Certificate of Training by a recognized institution in this field e.g. Academia Qualitas, Standard Council of Canada and Curriculum vitae. The first resource proposed listed sequentially will be evaluated. Additional resources proposed will not be evaluated for the purposes of the Technical Evaluation, however, all resources will be required to meet the minimum qualifications detailed under the Statement of Work. POINT RATED TECHNICAL EVALUATION CRITERIA : Point Rated Technical Evaluation Criteria are included in Part 4 of the bid solicitation. BASIS OF SELECTION : Basis of Selection - Highest Combined Rating of Technical Merit and Price 1. To be declared responsive, a bid must: (a) comply with all the requirements of the bid solicitation; and, (b) meet all mandatory criteria; and, (c) obtain the required minimum of 220 points out of a total of 294 points for criterion PR-1, and the minimum required score must be achieved in each sub criterion in order to be considered responsive; and, (d) obtain the required minimum of 86 points out of a total of 115 available points (75%) for criteria PR-2 to PR-6; and, (e) comply with the Laboratory Facility Evaluation Visit Checklist; and, (f) demonstrate that all proposed Chemists have successfully passed the Chemist Qualification Test; and, (g) demonstrate that the proposed Laboratory has successfully completed a scope expansion to cover Forensic Equine Drug Testing in accordance with CAN-P-1578, Appendix 4. 2. Bids not meeting items (a) or (b) or (c) or (d) or (e) or (f) or (g) will be declared non-responsive. 3. The selection will be based on the highest responsive combined rating of technical merit and price. The ratio will be 70% for the technical merit and 30% for the price. CONTRACTING AUTHORITY : Heather Wilson Supply Specialist Public Works and Government Services Canada Acquisitions Branch Science Procurement Directorate Place du Portage, Phase III, 11C1 11 Laurier Street Gatineau, Quebec K1A 0S5 Telephone: (819) 956-1354 Facsimile: (819) 997-2229 E-mail address: Heather.Wilson@tpsgc-pwgsc.gc.ca All enquiries must be submitted in writing to the Contracting Authority no later than ten (10) calendar days before the bid closing date.

Business analyst

Health Canada | Published October 27, 2014
cpvs

TASK Based Professional Services (TSPS) Requirement This requirement is for: Health Canada This requirement is open only to those Supply Arrangement Holders under E60ZN-13TSPS/ who qualified under Tier “ 1 ” (= $0-$2M ) stream two for Business Consulting / Change Manaagement This requirement is open only to those invited TSPS Supply Arrangement Holders who qualified under the stream for: Business Analyst The following SA Holders have been invited to submit a proposal. Accenture Inc. Access Corporate Technologies Inc. Chazey Partners Canada Inc. Eclipsys Solutions Epixus Inc. Excelsa Technologies Consulting Inc. Fujitsu Consulting (Canada) Inc. NATTIQ MHPM Project Managers Inc. OLAV Consulting Corp., MOSHWA Aboriginal Information Technology Corporation, in Joint Venture OpenFrame Technologies, Inc. S.i. Systems Ltd Sierra Systems Group Inc. The Strategic Review Group Inc. Transpolar Technology Corporation and The Halifax Computer Consulting Group in Joint Venture Description of the requirement: Health Canada has a requirement for a Business Analyst to do a feasibility assessment of developing a Canadian surveillance system for poisonings, chemical intoxications and adverse drug reactions, using data generated by five Canadian Regional Poison Control Centres. At the completion of the contract a business case, developed in accordance with Treasury Board guidelines, will be delivered to the Health Portfolio Task Force on a Canadian Surveillance System for Poison Information. The business case will be used to inform senior management decision making on the potential development of a Canadian Surveillance System for Poison Information (CSSPI). Security Requirement: The successful supplier will have a Designated Organizational Screening (DOS) as granted by the Canadian Industrial Security Directorate (CISD) and the resource(s) assigned to perform the work will have a Reliability status as granted by CISD. There is no Document Safeguarding Capability (DSC) required for this work. Proposed period of contract: The proposed period of contract shall be from November 17, 2014 to April 17, 2015. File Number: 1000163953a Contracting Authority: Robert Merrick Phone Number: 613-946-3159 E-Mail: Richard.Wootton @hc-sc.gc.ca Robert.Merrick@hc-sc.gc.ca NOTE: The Task and Solutions Professional Services (TSPS) Method of Supply is subject to quarterly refresh cycles. If you wish to find out how you can be a “Qualified SA Holder”, please contact SPTS.TSPS@TPSGC-PWGSC.GC.CA

R613.4 Laboratory determination of sealing material performance

Canadian Nuclear Safety Commission | Published November 3, 2014
cpvs

Annex A – Statement of Work 1. Objective The objective of this research is to obtain laboratory data on the performance of bentonite seal materials in a brine environment. The data are will be used in the development of numerical models by the CNSC to assess the long-term performance of sealing materials for repositories in sedimentary rock. 2. Background Two initiatives for the deep geological disposal of radioactive wastes are currently being proposed for Canada, and are being evaluated and investigated by the CNSC. The proposed repositories rely on both the surrounding host rock and engineered barriers to contain and isolate waste from the biosphere for hundreds of thousands to millions of years. The success of both projects depends largely on the long term performance of these barriers. CNSC has developed a Coordinated Assessment and Research Program on the safety of geological repositories (CARP). This program examines the long term performance of both the geological and engineered barriers. Over the long term, the host rock is a natural and major barrier to contaminant migration from repository waste. Therefore, the previous phase of CARP focused on geoscientific aspects of the host rock. However, preliminary long term safety assessments performed by the Nuclear Waste Management Organization (NWMO) have shown that bentonite seals used in the repository galleries and shafts also play an important role by minimizing preferential pathways for contaminant transport. Therefore, the current phase of the CARP is being extended to examine the long term performance of those engineered barriers. The CNSC collaborates with the IRSN (the Institut de Radioprotection et de Sûreté Nucléaire, France) in the SEALEX project, which involves a series of in-situ tests on the long term performance of sealing materials at the IRSN’s Tournemire underground research laboratory. The SEALEX project provides the CNSC with a wealth of experimental data that allows the CNSC to develop mathematical models for the long term performance of those sealing materials. One particular feature of Canadian sedimentary rocks is the existence of brine at anticipated repository depths of more than 500 m [1]. Experimental evidence shows that salinity plays an important role on the hydraulic, chemical and mechanical characteristics of bentonite seals. However, the experiments conducted so far were only performed at salinity concentrations much lower than the 200-300 g/l concentration levels of Canadian brines. For repositories proposed in Canadian sedimentary rocks, there is therefore a strong need to understand the interaction of the brine and the bentonite-based seals, in order to assess their long term performance as a barrier to water and gas flow. 3. References [1] NWMO, 2011. OPG’s Deep Geologic Repository for Low and Intermediate Level Waste: Geosynthesis. Report NWMO DGR-TR-2011-11 (http://www.nwmo.ca/dgrsubmission) [2] Barnichon J.D. and Deleruyelle F. Sealing experiments at the Tournemire URL: the SEALEX Project. Eurosafe 2009 [3] Barnichon J.D., Dick P. and Bauer C. (2011) The SEALEX in situ experiments: Performance tests of repository seals. In: Harmonising Rock Engineering and the Environment – Qian & Zhou (eds) © 2012 Taylor & Francis Group, London, ISBN 978-0- l415-80444-8, pp. 1391-1394 [4]DECOVALEX 2015- description of task A: http://www.decovalex.org/task-a.html [5]Wang, Q., Tang, A.M., Cui, Y., Delage, P., Barnichon, J.D., Ye, W.M (2013). The effects of technological voids on the hydro-mechanical behaviour of compacted bentonite-sand mixture. Soils and foundations 53, 2 (2013) 232-245 4. Scope of Work Perform laboratory tests to obtain hydro-mechanical characteristics and simulated long term evolution of a 70-30 bentonite-sand mixture, using brine as pore water. Laboratory testing will need to extend over a period of at least 2 years. 5. Tasks to be Performed 5.1 Design and produce a model water to represent porewater in the Cobourg limestone of the Michigan Basin, at depths of approximately 700 m. 5.2 Prepare MX-80 bentonite at a dry density of 1.61 and 1.41 Mg/m3. Prepare MX-80 bentonite/sand mixture similar to the ones used in the SEALEX project [2, 3] at dry densities of 1.65, 1.8 and 1.95 Mg/m3. 5.3 Perform oedometer and hydration tests on MX-80 and MX-80 bentonite/sand mixture with the model water to determine water retention, swelling pressure and other index properties (e.g. swell index). 5.4 Perform a parallel study of microstructure properties to observe changes over time. 5.5 Perform “mock-up” tests with a technological void similar to the one described in [4, 5]. The bentonite/sand mixture at an initial dry density of 1.95 Mg/m3 will be used in these tests. Instead of steel cells, the contractor should consider using hollow cylindrical samples of Cobourg Limestone as confining vessels. Perform gas/liquid injection test in one sample after the technological void has been filled and a steady-state swelling pressure is reached. 5.6 Perform chemical testing of pore waters over time and measure the cation exchange capacity after testing.

CBRN Moulded Butyl Rubber Gloves

Royal Canadian Mounted Police | Published November 12, 2014
cpvs

Requirement: CBRN Moulded Butyl Rubber Gloves with Liner in various sizes The RCMP, Chemical Biological Radiological Nuclear (CBRN) First Responder Program (FRP) has a requirement for a firm quantity of 612 pairs CBRN Moulded Butyl rubber gloves, complete with liner in various sizes. The proposed procurement includes an option to purchase an additional maximum quantity of 5,000 pairs CBRN Moulded Butyl rubber gloves complete with liner on an ‘'as and when'’ requested basis during a 5 year period from date of contract award. The firm quantity of 612 is requested to be delivered sixty (60) calendar days from the effective date of contract award. GSIN: N8415 Applicable Trade Agreements: AIT This requirement is limited to authorized Airboss Defense Canadian distributors and or resellers. The RCMP will not accept any substitute product for this requirement. The Responsive Bid with the lowest evaluated price will be recommended for award of a contract. There will only be one contract awarded as a result of this solicitation. Delivery to be made to The Royal Canadian Mounted Police in Ottawa, Ontario. The Bidder must ensure that the required pre-award sample is manufactured in accordance with the technical requirement and is fully representative of the bid submitted. Rejection of the pre-award sample will result in the bid being declared non-responsive. The Crown reserves the right to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. For more information on The RCMP National Procurement Plan for fiscal year 2014-2015 please visit http://www.rcmp-grc.gc.ca/pubs/cm-gg/index-eng.htm

MIDAS Database for International Price Comparison

Patented Medicine Prices Review Board | Published November 25, 2014
cpvs

TITLE: MIDAS Database for International Price Comparison: Top Selling Canadian Off-patent Multiple Source Drug Products Off-patent Single Source Drug Products Patented Drug Products. Solicitation Number: 15NL029 1. The purpose and explanation of an ACAN An Advance Contract Award Notice (ACAN) allows the Patented Medicine Prices Review Board (PMPRB) to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that a goods, services or construction contract will be awarded to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the minimum requirements identified in the ACAN, the Contracting Authority may then proceed to award a contract to the pre-identified contractor. 2. Rights of suppliers Suppliers who consider themselves fully qualified and available to provide the services or goods described in this ACAN may submit a Statement of Capabilities demonstrating how they meet the advertised requirement. This Statement of Capabilities must be provided via e-mail only to the contact person identified in Section 12 of the Notice, on or before the closing date and time of the Notice. If the Bidder can clearly demonstrate they possess the required capabilities, the requirements will be opened to electronic or traditional bidding processes. 3. Proposed Contractor IMS AG Doftplatz4, 6330 Cham Switzerland 4. Definition of Requirements or Expected Results The PMPRB requires drug utilization information for the retail and hospital sector respecting relevant market variables such as price (at ex-factory, wholesale and retail level in local and US currency), quantities and revenue of medicines sold in Canada and all OECD countries. The information must be collected in a complete, objective and non-biased fashion by surveying hospitals, pharmacies and wholesalers across Canada and all OECD countries. IMS AG has two products (IMS Midas Quantum Data Elements, Measure and Statistics, and IMS Midas Market Segmentation) which contain detail level data not available from any other source. The PMPRB, on an annual basis, develops a research agenda based on input from a National Prescription Drug Utilization Information System (NPDUIS) Advisory Committee (AC). The NPDUIS is a federal/provincial/territorial initiative that provides critical analysis of price, utilization, and cost trends to support policy-making by federal government and provincial public drug plans. The results of NPDUIS studies, which are often conducted at the request of provincial or territorial partners, are often published in the form of research reports and made available to the general public. International price and market trends continue to be areas of research for both PMPRB policy work and as part of research priorities identified by the NPDUIS AC. 5. Minimum requirements Any interested supplier must demonstrate by way of a Statement of Capabilities that it meets the following minimum requirements: A) Deliverables Price information for all OECD countries for top selling 100 off-patent multiple source molecules; top selling 25 off-patent single source molecules; top selling 50 patented molecules for 2006 to year to date. This database contains the following information: • Prices and Canadian utilization information (by market segmentation: off-patent, patent, multiple source, single source, generics or unbranded, branded, company branded generics and original off-patent brand). Canadian data to include quantity and prescriptions dispensed and cost for each period of analysis. • Data should be grouped by three categories: top selling 100 off-patent multiple source molecules with generic copies in Canada and with generic sales in at least three other countries (listed below) for the same period; top selling 25 off-patent single source molecules in Canada; and 50 top selling patented drug products. • Top selling is defined in Canada for latest available data for 2014 • Prices, market segment and number of manufacturers information for all OECD countries for each group of drugs separated by market segment and time period • For all OECD countries, include aggregate data for all drug groupings, ie. off-patent multiple source, off patent single source and patented and include total quantity, number of Rx’s and cost (in local currency). • All data (international data and Canadian data) to be expressed as median, minimum and maximum price separated by the hospital and retail sector and wholesale, retail and ex-factory gate level separated by market segment (as defined above). • Number of unique manufacturers and corporations for each molecule and by market segment • Product market protection information must be included. • All data to include name and price at manufacturer level with a brand/generic identifier and multiple/single source identifier. Median, minimum and maximum price to be reported at hospital and retail level separately. Separated to the wholesale, retail and ex-factory gate level. • Time period: 2006 to year to date • Price information to be provided in local and US currency, by geographical area and years • Price for each category of drugs and market segment will be defined as a straight average of $/units. • Analysis will be restricted to oral form only. • Information being reported at the following levels: time period (quarter), country, market segment, manufacturer, ingredient, strength, form, packsize Selected Data Elements (16) 1. Country 2. Sector 3. Corporation 4. Manufacturer 5. ATC4 6. International product name 7. Domestic Product name 8. Molecule 9. INTRX (prescription status) 10. GEN PRD (generic status) 11. E-DT PRTEXP (protection expiry date) 12. New Form Code 3 13. INTSTR (International Strength) 14. International Size (INTSIZE) 15. International Volume (INTVOL) 16. Chemical Salt Specifications and Standards • Top selling is defined by Canadian market • Price is defined as average price per counting units • The results shall be provided in Microsoft Excel or other compatible software 6. Reason for non-competitive award In accordance with the Government Contracts Regulations (GCR) of the Financial Administration Act, the following request falls under exception 6(d) of the GCR, which stipulates that only one person or contractor is capable of performing the contract. IMS AG is the only company to collect the required information in the required complete, objective and non-biased fashion, by surveying hospitals, pharmacies as well as wholesalers across Canada and all OECD countries. No other data supplier can provide the type of information that would be sufficient to our needs. The data supplied will add to an already existing database with the same specifications and would allow for consistent time horizon analysis. IMS Health has exclusive ownership of the MIDAS database. 7. Applicable trade agreements and justification for limited tendering This procurement is subject to the following: AIT- Limited tendering reason; where there is an absence of competition for technical reasons and the goods or services can be supplied only by a particular supplier and no alternative or substitute exists, As per Article 506 Paragraph12 (b) NAFTA- Limited tendering reason; the goods or services can be supplied only by a particular supplier and no reasonable alternative or substitute exists, As per Article 1016.2(B) WTO- Limited tendering reason; the products or services can be supplied only by a particular supplier and no reasonable alternative or substitute exists, As per Article XV (15), Paragraph 1 (b) 8. Ownership of Intellectual Property Ownership of any Foreground Intellectual Property arising out of the proposed contract will vest with the Contractor. 9. Period of the proposed contract The services of the contractor will be required for one year after the award of the contract. 10. Estimated value of the proposed contract The total estimated value of the proposed contract should not exceed $319,190.00 US including all option periods, travel and living expenses (if applicable), and all applicable taxes and a Total One-Time Cost of $4,033.00 US. 11. Closing date and time The closing date and time for accepting Statements of Capabilities is: X, January 2015 at 14:00h EST. 12. Contact Person All inquiries with regard to this Notice must be addressed by e-mail to: Name: Nadia Laneve E-Mail: nadia.laneve@pmprb-cepmb.gc.ca

CBRN Moulded Protective Gloves with Liner

Royal Canadian Mounted Police | Published December 31, 2014  -  Deadline December 1, 2015
cpvs

Requirement: CBRN Moulded Butyl Rubber Gloves with Liner in various sizes The RCMP, Chemical Biological Radiological Nuclear (CBRN) First Responder Program (FRP) has a requirement for a firm quantity of 612 pairs CBRN Moulded Butyl rubber gloves, complete with liner in various sizes. The proposed procurement includes an option to purchase an additional maximum quantity of 5,000 pairs CBRN Moulded Butyl rubber gloves complete with liner on an ‘'as and when'’ requested basis during a 5 year period from date of contract award. The firm quantity of 612 is requested to be delivered sixty (60) calendar days from the effective date of contract award. GSIN: N8415 Applicable Trade Agreements: AIT This requirement is limited to authorized Airboss Defense Canadian distributors and or resellers. The RCMP will not accept any substitute product for this requirement. The Responsive Bid with the lowest evaluated price will be recommended for award of a contract. There will only be one contract awarded as a result of this solicitation. Delivery to be made to The Royal Canadian Mounted Police in Ottawa, Ontario. The Bidder must ensure that the required pre-award sample is manufactured in accordance with the technical requirement and is fully representative of the bid submitted. Rejection of the pre-award sample will result in the bid being declared non-responsive. The Crown reserves the right to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. For more information on The RCMP National Procurement Plan for fiscal year 2014-2015 please visit http://www.rcmp-grc.gc.ca/pubs/cm-gg/index-eng.htm

Photoacoustic Extinctiometer

National Research Council | Published January 27, 2015
Winner
Droplet Measurement Technologies
cpvs

Trade Agreement: NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Exclusive Rights GSIN Description: Chemical Analysis Instruments Quantity: 1

Chemical Analysis Instruments

Health Canada | Published January 27, 2015
Winner
Agilent Technologies Canada Inc.
cpvs

Trade Agreement: WTO-AGP/NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Source List Contract Award Procedure (Procurement Strategy): Interchangeable Parts GSIN Description: Chemical Analysis Instruments Quantity: 1

HIGH TEMP. SIMUL. DISTILL. APPARAT.

Environment Canada | Published February 10, 2015
Winner
THERMO FISHER SCIENTIFIC (MISSISSAUGA) INC.
cpvs

Trade Agreement: NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Lowest/Lower Bid GSIN Description: Chemical Analysis Instruments Quantity: 1

GAS CHROMATOGRAPH (GC)

Agriculture & Agrifood Canada | Published February 11, 2015
Winner
THERMO FISHER SCIENTIFIC (MISSISSAUGA) INC.
cpvs

Trade Agreement: WTO-AGP/NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Lowest/Lower Bid GSIN Description: Chemical Analysis Instruments Quantity: 2

SEA MARKER, FLUORESCENT

Department of National Defence | Published February 17, 2015
Winner
Donald Shaw
cpvs

Trade Agreement: NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Lowest/Lower Bid GSIN Description: Miscellaneous Chemical Specialities Quantity: 3000

LIQ. CHROMATOGRAPH-MASS SPECTROM.

Health Canada | Published February 25, 2015
Winner
Waters Limited
cpvs

Trade Agreement: WTO-AGP/NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Lowest/Lower Bid GSIN Description: Chemical Analysis Instruments Quantity: 1

LIQUID CHROMATOGRAPHY MASS SPECTROMETER SYSTEM

Agriculture & Agrifood Canada | Published March 4, 2015
Winner
THERMO FISHER SCIENTIFIC (MISSISSAUGA) INC.
cpvs

Trade Agreement: WTO-AGP/NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Lowest/Lower Bid GSIN Description: Chemical Analysis Instruments Quantity: 1

CYLINDER, AIR, DIVING EQUIPMENT

Department of National Defence | Published March 5, 2015
Winner
Tulmar Safety Systems Inc.
cpvs

Trade Agreement: NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Lowest/Lower Bid GSIN Description: Miscellaneous Chemical Specialities

TSPS Technician - Intermediate Analytical Chemistry

Department of National Defence | Published March 16, 2015  -  Deadline March 31, 2015
cpvs

NOTICE OF PROPOSED PROCUREMENT This requirement is only open to the below list of pre-qualified suppliers under the Task and Solutions Professional Services (TSPS). TASK BASED E60ZN-13TSPS PROFESSIONAL SERVICES REQUIREMENT FILE NUMBER: DND 14/0030863 TIER 1 (< $2M) This requirement is for the Department of National Defence (DND). This requirement is for the Technical Engineering and Maintenance Services (TEMS) Class for the services of one (1) Technician, Level 2 and one (1) optional Technician, Level 2. Number of Contracts: One contract to be awarded. Request for Proposal (RFP) documents will be e-mailed directly, from the DND Point of Contact (DND POC), to the Qualified Supply Arrangement Holders who are being invited to bid on this requirement. BIDDERS ARE ADVISED THAT RFP DOCUMENTS ARE NOT AVAILABLE ON THE GOVERNMENT ELECTRONIC TENDERING SYSTEM (https://buyandsell.gc.ca/tenders). Location of Work to be Performed Region: National Capital Region (NCR) Specific Location: 45 Sacré-Cœur Boulevard, Gatineau, Quebec Security Requirement Security Requirements Check List: Common PS SRCL #20 Supplier Security Clearance required: Facility Security Clearance – Secret Security Level required (Document Safeguarding): None Enquiries: Enquiries regarding this RFP requirement must be submitted to the DND POC listed below. File Number: DND 14/0030863 DND POC: Amber Tower E-Mail: DSvcsC4Contracting-DCSvcs4Contrats@forces.gc.ca DND requires the services of one (1) Technician, Level 2 and one (1) optional Technician, Level 2 to support the activities of the Quality Engineering Test Establishment (QETE) Applied Science program. The resource(s) will provide qualitative and quantitative physical and chemical analytical services in support of failure/accident investigations, specialist test and evaluation as well as Materiel Acquisition and Support related tasks. This requirement will be from date of award to two (2) years later, with an irrevocable option for up to three (3) additional one-year option periods. Documents may be submitted in either official language of Canada. The TSPS Method of Supply is a result of a formal competitive process which was established as a result of extensive consultations with industry. The Method of Supply provides suppliers with an on-going opportunity to become pre-qualified for participation in future bidding opportunities. To obtain more information about how to become a pre-qualified supplier for TSPS, please contact Public Works and Government Services Canada (PWGSC) at: spts.tsps@tpsgc-pwgsc.gc.ca. For general information on the various PWGSC Methods of Supply, or to obtain specific information on a PWGSC professional service method of supply, please visit PWGSC's Buy and Sell website at: https://buyandsell.gc.ca/for-businesses/selling-to-the-government-of-canada/register-as-a-supplier/register-to-provide-services. List of Pre-Qualified Suppliers This requirement is open only to the following companies who qualified under the stated consultant categories, level of expertise, security level, region and tier: 1. ACF Associates Inc. 2. ADGA Group Consultants Inc. 3. Adirondack Information Management Inc., The AIM Group Inc. in Joint Venture 4. AEROTEK ULC 5. Altis Human Resources (Ottawa) Inc. 6. Amtek Engineering Services Ltd. 7. BMT Fleet Technology Limited 8. CAE Inc. 9. Calian Ltd. 10. Fleetway Inc. 11. GasTOPS Ltd. 12. International Safety Research Inc. 13. Michael Wager Consulting Inc. 14. Modis Canada Inc. 15. Noramtec Consultants Inc. 16. Orbis Risk Consulting Inc. 17. Platinum Technologies Inc. 18. Promaxis Systems Inc. 19. T.E.S. Contract Services Inc. 20. The AIM Group Inc. 21. Valcom Consulting Group Inc.

Provincial Reimbursement Advisor (PRA), PharmaFocus (PF) and Canadian Drug Stores and Hospital Purchases Audit (CD&H)

Patented Medicine Prices Review Board | Published March 20, 2015  -  Deadline July 4, 2015
cpvs

1. The purpose and explanation of an ACAN An Advance Contract Award Notice (ACAN) allows the Patented Medicine Prices Review Board (PMPRB) contracting authorities to post a notice on MERX, for no less than fifteen (15) calendar days, indicating to the supplier community that a good, service or construction contract will be awarded to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process. 2. Rights of suppliers Suppliers who believe that they are fully qualified and available to provide the services or goods described in this ACAN may submit a Statement of Capabilities clearly demonstrating how they meet the advertised requirement. This Statement of Capabilities must be provided via e-mail only to the contact person identified in Section 12 of the Notice on or before the closing date and time of the Notice. If there is a reasonable level of evidence regarding capability, the requirements will be opened to electronic or traditional bidding processes. 3. Proposed Contractor IMS Health Canada Inc. doing business as IMS Brogan Canadian HQ 16720 Trans-Canada Highway Kirkland, Quebec H9H 5M3 4. Definition of Requirements or Expected Results The PMPRB requires drug information respecting quantities and revenue of medicines sold in Canada. The information must be collected in a complete, objective and non-biased fashion by surveying hospitals, pharmacies and wholesalers across Canada. The PMPRB also requires publications and associated subscription services that provide regular updates on federal and provincial/territorial policy changes related to pharmaceuticals, public drug plan design and coverage, prices and developments of the Common Drug Review and the recommendations of the Canadian Expert Drug Advisory Committee; as well as information on the latest Notice of Compliance as well as statistics and intelligence on the Canadian pharmaceutical market. 5. Minimum requirements Any interested supplier must demonstrate by way of a Statement of Capabilities that it meets the following minimum requirements: A) Deliverables 1. Two (2) print subscriptions to the quarterly Provincial Reimbursement Advisor (PRA) report (published in February, May, August and November of each calendar year), which shall contain provincial and federal drug reimbursement information which is publicly available; able to be used in PMPRB publications (e.g.. Annual reports, research studies, speeches, etc.); contain the latest information on provincial and federal coverage; contain information on prices and sales of new chemical entities and drug classes; contain information on recent developments of the Common Drug Review and the recommendations of the Canadian Expert Drug Advisory Committee; as well as contain information on the latest Notice of Compliance. 2. Two (2) subscriptions, in the format of a compact disk (CD), to the Formulary Acceptance: Monitoring and Evaluation (FAME) Database, updated on a quarterly basis, which shall provide an overview of major new pharmaceutical product and category listings across Canada and shall contain all recent product introductions and their listing status on each provincial formulary and the Non-Insured Health Benefits formulary. 3. Electronic subscriptions, delivered via e-mail, to the PRA Weekly publication, which shall provide weekly information updates on important developments, listings, or personnel changes that impact market access and reimbursement decisions in Canadian pharmaceutical management policy. 4. One (1) print subscription to the annual PRA Compendium publication, which is a source of information on provincial contacts, advisory committees, submission requirements and guidelines. 5. Internet-based access, to current and archived issues of the PRA quarterly report, the PRA Weekly report and related information products. 6. Two (2) print subscriptions to the annual in-depth PharmaFocus Ten providing a comprehensive, independent review of the Canadian pharmaceutical marketplace, including a semi-annual update. 7. Electronic subscriptions, delivered via e-mail, to the Pharma Focus Monthly Market Monitor which provides the most current statistics and intelligence on the performance of the Canadian pharmaceutical market, as well as quantitative and qualitative analysis of the most important market trends and strategic insights. 8. Electronic subscriptions, delivered via email, to the PharmaFocus weekly email updates on health reform developments and pharmaceutical news in Canada. 9. Monthly national and regional subscriptions in the form of a CD to the Canadian Drug Store and Hospital Audit (CDH), which shall contain comprehensive information on brand name and generic drug product sales by manufacturers to hospitals and drugstores in Canada. The information on sales data shall be based on surveys conducted on samples of drug stores and hospitals to reflect purchases throughout Canada. The subscription data shall be publicly available; able to be used in PMPRB publications (e.g. Annual reports, summary reports on individual drug products, price review process, speeches, etc.); contain the product name, manufacturer name, product dosage form, product strength, sales and quantity sold for each brand name and generic product (this information is to be used for the verification of the price and sales information filed by the pharmaceutical company to the PMPRB as well as source of publicly available ex-factory prices for the price review process and for inclusion in published summary reports); contain the aggregate sales for each individual brand name and generic drug product [to allow the calculation of market share by therapeutic class, the calculation of market share by individual medicine, the calculation of the non-patented sales portion of total sales for all provinces for a given year and the use of the information for verification purposes (e.g. sales at aggregate level and by class of customer; of quantities sold; for calculation of R&D ratios)]. The June CD must contain the total sales for the first six months of the year (i.e. January to June) and the December CD must contain sales for the previous twelve months (i.e. January to December). B) Information type and its method of collection The PMPRB requires drug information respecting quantities and revenue of medicines sold in Canada. The information must be collected in a complete, objective and non-biased fashion by surveying hospitals, pharmacies and wholesalers across Canada. 6. Reason for non-competitive award In accordance with the Government Contracts Regulations (GCR) of the Financial Administration Act, the following request falls under exception 6d of the GCR, which stipulates that only one person or contractor is capable of performing the contract. IMS Health Canada is the only company to collect the required information in the required complete, objective and non-biased fashion, by surveying hospitals, pharmacies as well as wholesalers across Canada. No other data supplier can provide the type of information that would be sufficient to our needs. IMS Health Canada is the only company to provide the PRA quarterly and the PRA weekly which provides the most comprehensive summary of federal and provincial/territorial policy changes related to pharmaceuticals, public drug plan design and coverage, prices and developments of the Common Drug Review and the recommendations of the Canadian Expert Drug Advisory Committee; as well as information on the latest Notice of Compliance. 7. Applicable trade agreements and justification for limited tendering or the Procurement Strategy for Aboriginal Business This procurement is subject to the Agreement on Internal Trade (AIT), North American Free Trade Agreement (NAFTA) and the World Trade Agreement-Agreement on Government Procurement (WTO-AGP) NAFTA- Limited tendering reason; the goods or services can be supplied only by a particular supplier and no reasonable alternative or substitute exists, As per Article 1016.2(B) O- Limited tendering reason; the products or services can be supplied only by a particular supplier and no reasonable alternative or substitute exists, As per Article XV (15), Paragraph 1 (b) AIT- Limited tendering reason; where there is an absence of competition for technical reasons and the goods or services can be supplied only by a particular supplier and no alternative or substitute exists, As per Article 506 Paragraph12 (b) 8. Ownership of Intellectual Property Ownership of any Foreground Intellectual Property arising out of the proposed contract will vest with the Contractor. 9. Period of the proposed contract The proposed contract is for a period of one (1) year, from April 1, 2015 to March 31, 2016 with an irrevocable option on the part of Canada to extend the period of any resulting contract by up to four (4) additional one (1) year periods. 10. Estimated value of the proposed contract The total estimated value of the proposed contract should not exceed $736,698.98 including all option periods, travel and living expenses (if applicable), and all applicable taxes. 11. Closing date and time The closing date and time for accepting Statements of Capabilities is: April 7, 2015 14:00 Eastern Daylight time (EDT) 12. Contact Person All inquiries with regard to this Notice must be addressed by e-mail to: Name: Nadia Laneve E-Mail: nadia.laneve@pmprb-cepmb.gc.ca

Photo Pouches

Citizenship & Immigration Canada | Published March 24, 2015  -  Deadline April 5, 2015
cpvs

Trade Agreement: WTO-AGP/NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Tendering Procedures: All interested suppliers may submit a bid Attachment: None Competitive Procurement Strategy: Lowest/Lower Bid Comprehensive Land Claim Agreement: No Nature of Requirements: Photo Pouches B8297-150490/A Swanson, Manon Telephone No. - (819) 956-7304 ( ) Fax No. - (819) 956-5706 The Contractor must provide photo pouches in accordance with the Statement of Requirement at Annex "A" and the Pricing at Annex "B" on an "as and when" required basis for Citizenship and Immigration Canada (Forms Management), Ottawa, Ontario The period of the Contract is from date of Contract for a period two (2) years. First delivery: 600,000 photo pouches The Contractor grants to Canada the irrevocable option to extend the term of the Contract by up to 3 additional twelve month periods . SPECIFICATIONS Outside dimensions: 2.375" wide x 3" high Inside dimensions: 1.875" wide x 2.5" high (cannot be smaller) Opening style: K-295 Back load Opening: on 2 3/8" from bottom Back: Gummed, peelable back, split at 5/8" from top Top gauge: 2.00 mil Polyethylene density: Low density (Polyethylene is the only acceptable chemical compound to be used for CIC photo pouches. No other products will be accepted.) Destination: Ottawa, Ontario Delivery Date: Above-mentioned The Crown retains the right to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada.

JET FUEL THERMAL STABILITY ADDITIVE

Department of National Defence | Published April 7, 2015
Winner
GE Betz Canada
cpvs

Trade Agreement: WTO-AGP/NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Lowest/Lower Bid GSIN Description: Miscellaneous Chemical Specialities Quantity: 2

Miscellaneous Chemical Specialities

Department of National Defence | Published April 29, 2015
Winner
Chevron Canada Limited
cpvs

Trade Agreement: WTO-AGP/NAFTA/AIT/Canada FTAs with Peru/Colombia/Panama Comprehensive Land Claim Agreement: No Notification Method: Public Advertising (MERX/GBO) Contract Award Procedure (Procurement Strategy): Interchangeable Parts GSIN Description: Miscellaneous Chemical Specialities Quantity: 500

RFI for Radiation Detection System

Department of National Defence | Published May 8, 2015  -  Deadline May 29, 2015
cpvs

Trade Agreement: NONE Tendering Procedures: Attachment: None Competitive Procurement Strategy: N/A - P&A/LOI Only Comprehensive Land Claim Agreement: No Nature of Requirements: RFI for Radiation Detection System W8476-16RDS1/A Beach, Isabelle Telephone No. - (819) 956-3467 Request for Information Joint Chemical Biological Radiological Nuclear Detection System (Joint CBRN RDS) Project. Department of National Defence (DND) Delivery Date: 29/05/2015 The Crown retains the right to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada.